Results 131 to 140 of about 5,279 (205)

Nirmatrelvir-Ritonavir-Induced Pancreatitis: A Concern in the COVID Era. [PDF]

ACG Case Rep J
DeBroff J, Abraham J, Yoon BH, Cohen I.
europepmc   +1 more source

Patient-reported improvements from use of IMC-2 alone and IMC-2 and Paxlovid^® in a Long COVID cohort: a case series. [PDF]

Front Immunol
Pridgen WL, Putrino D.
europepmc   +1 more source

Use of Rifampicin as a Cytochrome Inducer in Acute Tacrolimus Poisoning. [PDF]

Open Respir Arch
Margallo Iribarnegaray J, Alonso Moralejo R, Quezada Loaiza CA, Ortega Ruiz L, Ruiz Rodriguez M, De Pablo Gafas A.   +5 more
europepmc   +1 more source

Clinical characteristics and risk factors associated with mortality in hospitalized patients with COVID-19 aged 90 years or older. [PDF]

Medicine (Baltimore)
Wu M, Yin Q, Cao Y, Zheng K, Cai J, Wang W, Hu Y, Guan H, Ren Q, Zhu H, Lan X, Zhu W.   +11 more
europepmc   +1 more source

Who bears liability when AI gives bad prescribing advice. [PDF]

NPJ Digit Med
Etkin JS, Joralemon V.
europepmc   +1 more source

Effect of Paxlovid on Skeletal System Morphogenesis in Animal Model Rat (Morphological Study). [PDF]

Med J Islam Repub Iran
Abdollahi A, Morovati-Sharifabad M, Salehi E, Rashidi M, Rezaei-Golmisheh A.   +4 more
europepmc   +1 more source

Severe HCoV-OC43 Pneumonia in a 25-Year-Old Woman Following Allogeneic Hematopoietic Stem Cell Transplantation. [PDF]

Clin Respir J
Zhang M, Tang T, Zheng M, Luo M, Xu Z, Wang G.   +5 more
europepmc   +1 more source

Convalescent plasma for persistent symptomatic COVID-19 infection in immune-suppressed patients - a case series. [PDF]

Infect Med (Beijing)
Ronen D, Karameh M, Padawer D, Alsharif N, Elghaffar Yaghmour A, Elinav H, Fridlender ZG.   +6 more
europepmc   +1 more source

Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment \u2014 California, December 2021\u2013May 2022

What is already known about this topic? Recurrence of COVID-19 symptoms and positive SARS-CoV-2 test results have been reported after completion of Paxlovid oral antiviral treatment for COVID-19, but real-world evidence of severe illness following ...

core  

A retrospective cohort study of viral and sociodemographic determinants of long COVID among Idaho veterans. [PDF]

Front Public Health
Taylor I, Boyd JK, McIndoo E, Ammons MCB.   +3 more
europepmc   +1 more source